| 703398 |
FRONTIERS IN ONCOLOGY |
Disparity in Access to Oncology Precision Care: A Geospatial Analysis of Driving Distances to Genetic Counselors in the U.S. |
2021-06-16 |
10.3389/fonc.2021.689927 |
Bellaiche Mathias M. J., Fan Winnie, Walbert Harold John, McClave Egan H., Goodnight Bradley L., Sieling Fred H., Moore Rebekah A., Meng Weilin, Black Christopher M. |
| 703397 |
FRONTIERS IN ONCOLOGY |
Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade |
2021-06-16 |
10.3389/fonc.2021.701345 |
Olsen T. Anders, Martini Dylan J., Goyal Subir, Liu Yuan, Evans Sean T., Magod Benjamin, Brown Jacqueline T., Yantorni Lauren, Russler Greta Anne, Caulfield Sarah, Goldman Jamie M., Harris Wayne B., Kucuk Omer, Carthon Bradley C., Master Viraj A., Nazha Bassel, Bilen Mehmet Asim |
| 703396 |
FRONTIERS IN ONCOLOGY |
Clinical Characteristics and Prognosis of Renal Cell Carcinoma With Spinal Bone Metastases |
2021-06-16 |
10.3389/fonc.2021.659779 |
Zhai Jianpo, Liu Ning, Wang Hai, Huang Guanglin, Man Libo |
| 703395 |
FRONTIERS IN ONCOLOGY |
Comprehensive Characterization of Integrin Subunit Genes in Human Cancers |
2021-06-16 |
10.3389/fonc.2021.704067 |
Cui Kaisa, Wu Xiaohan, Gong Liang, Yao Surui, Sun Shengbai, Liu Bingxin, Zhou Mingyue, Yin Yuan, Huang Zhaohui |
| 703394 |
FRONTIERS IN ONCOLOGY |
Comparative Risk of Renal Adverse Events in Patients Receiving Immune Checkpoint Inhibitors: A Bayesian Network Meta-Analysis |
2021-06-16 |
10.3389/fonc.2021.662731 |
Liu Kang, Qin Zhongke, Xu Xueqiang, Li Ting, Ge Yifei, Mao Huijuan, Xing Changying |
| 703393 |
FRONTIERS IN ONCOLOGY |
Inflammatory Environment Promotes the Adhesion of Tumor Cells to Brain Microvascular Endothelial Cells |
2021-06-16 |
10.3389/fonc.2021.691771 |
Wang Ke, Dong Shuang, Higazy Doaa, Jin Lijing, Zou Qingcui, Chen Haowei, Inayat Aakif, Hu Sheng, Cui Min |
| 703392 |
FRONTIERS IN ONCOLOGY |
Hypofractionated Volumetric-Modulated Arc Radiotherapy for Patients With Non-Small-Cell Lung Cancer Not Suitable for Surgery or Conventional Chemoradiotherapy or SBRT |
2021-06-16 |
10.3389/fonc.2021.644852 |
Shen Junyue, Yang Dan, Chen Mailin, Jiang Leilei, Dong Xin, Li Dongming, Yu Rong, Yu Huiming, Shi Anhui |
| 703391 |
FRONTIERS IN ONCOLOGY |
Prior Therapy With Pegylated-Interferon Alfa-2b Improves the Efficacy of Adjuvant Pembrolizumab in Resectable Advanced Melanoma |
2021-06-16 |
10.3389/fonc.2021.675873 |
Jia Dong-Dong, Niu Yanling, Zhu Honglin, Wang Sizhen, Ma Tonghui, Li Tao |
| 703390 |
FRONTIERS IN ONCOLOGY |
Late Gastrointestinal Tolerance After Prostate Radiotherapy: Is the Anal Canal the Culprit? A Narrative Critical Review |
2021-06-16 |
10.3389/fonc.2021.666962 |
Sargos Paul, Faye Mame Daro, Bacci Manon, Supiot Stéphane, Latorzeff Igor, Azria David, Niazi Tamim M., Vuong Te, Vendrely Véronique, de Crevoisier Renaud |
| 703389 |
FRONTIERS IN ONCOLOGY |
Targeting Immunometabolism in Glioblastoma |
2021-06-16 |
10.3389/fonc.2021.696402 |
Mohan Aditya A., Tomaszewski William H., Haskell-Mendoza Aden P., Hotchkiss Kelly M., Singh Kirit, Reedy Jessica L., Fecci Peter E., Sampson John H., Khasraw Mustafa |
